Jones John Jude 4
4 · MARSH & MCLENNAN COMPANIES, INC. · Filed Mar 7, 2025
Insider Transaction Report
Form 4
Jones John Jude
Chief Marketing Officer
Transactions
- Exercise/Conversion
Common Stock
2025-03-06$117.53/sh+5,057$594,349→ 13,035 total - Exercise/Conversion
Stock Options (Right to Buy)
2025-03-06−5,057→ 0 totalExercise: $117.53Exp: 2031-02-21→ Common Stock (5,057 underlying) - Sale
Common Stock
2025-03-06$235.37/sh−4,743$1,116,362→ 7,978 total - Exercise/Conversion
Stock Options (Right to Buy)
2025-03-06−4,743→ 0 totalExercise: $118.86Exp: 2030-02-18→ Common Stock (4,743 underlying) - Exercise/Conversion
Common Stock
2025-03-06$118.86/sh+4,743$563,777→ 12,721 total - Sale
Common Stock
2025-03-06$234.84/sh−5,057$1,187,584→ 7,978 total - Sale
Common Stock
2025-03-06$235.60/sh−1,024$241,260→ 7,978 total
Holdings
- 1,745.077(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]This transaction was executed in multiple trades at prices ranging from $234.790 to $235.050. The price reported represents the weighted average sale price of these trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price.
- [F2]These options were granted on February 19, 2020 and vested in four equal annual installments on February 19th of 2021, 2022, 2023 and 2024
- [F3]These options were granted on February 22, 2021 and vested in four equal annual installments on February 22nd of 2022, 2023, 2024 and 2025.